Neviah Genomics Ltd
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Neviah Genomics Ltd
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
Prexton Therapeutics will be headquartered at the Eclosion incubator facility in Geneva and will advance mGluR compounds for Parkinson’s from the Merck Serono portfolio.
Brief profiles of these recently formed companies: BriteSeed, Cool-Bio, Euclises Pharmaceuticals, Global Blood Therapeutics, Magenta Medical and Neviah Genomics.
- Contract Research, Toxicology Testing-CRO
- Drug Discovery Tools